Telenor maintains India peak funding target

OSLO Fri Dec 14, 2012 1:18pm IST

A visitor rests under a Telenor Group sign at the GSMA Mobile World Conference in Barcelona February 18, 2009. REUTERS/Gustau Nacarino/Files

A visitor rests under a Telenor Group sign at the GSMA Mobile World Conference in Barcelona February 18, 2009.

Credit: Reuters/Gustau Nacarino/Files

Related Topics

Stocks

   

OSLO (Reuters) - Telenor (TEL.OL) will stick to its peak funding target in India, the world's second-biggest mobile market, where it expects to break even by the end of next year after scaling back operations.

The Norwegian telecoms operator has set a peak funding cap of 155 billion Indian rupees, or about 16 billion Norwegian crowns for its Indian operations and recently reduced its presence in the country to stay below the limit.

The funding needs until break even are moderate, it said in a slide ahead of a presentation on Friday

"The most important thing is that they say they don't need to invest more money," said Espen Torgersen, an analyst at brokerage Carnegie.

"But what about 3G and what about M&A? Are there new so called business cases that are not included in the 155 billion rupees?" he added.

India's mobile market is less concentrated than other telecom markets and Telenor said the inevitable consolidation could present opportunities to build muscle.

Telenor won back its telecom operating licences in six of India's most populous states in an auction last month, after Indian authorities had cancelled 122 operating permits awarded in a corruption-tainted licensing round, forcing Telenor and others to reapply.

Telenor originally had licences in 13 circles and the Indian unit has never made a net profit.

While India's more than 900 million mobile phone customers make it the world's second-biggest market after China, intense competition among 15 carriers means wafer-thin margins.

Telenor's Uttar Pradesh East circle has achieved break-even after three years, and Telenor expects its Gujarat and Maharashtra to break even in early 2013, it said.

The cost of acquiring its six new licences was 4.2 billion crowns and the firm targets above 25 percent equity return on new money invested in India (Reporting by Victoria Klesty; Editing by Balazs Koranyi)

FILED UNDER:
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Drug Pricing

REUTERS SHOWCASE

Modi Speaks

Modi Speaks

PM Modi says al Qaeda will fail in India - CNN.  Full Article 

Price Cap

Price Cap

India caps prices of 36 more drugs to improve access - govt official.  Full Article 

India-US Diplomacy

India-US Diplomacy

Obama to nominate Indian-American Richard Verma as India ambassador - congressional source.  Full Article 

Importing Rice

Importing Rice

Top rice exporter India importing over 100,000 T on temporary supply squeeze.  Full Article 

GSK Fined

GSK Fined

China hands drugmaker GSK record $489 mln fine, sentences executives.  Full Article 

HMT in Demand

HMT in Demand

Fans rush to HMT as watchmaker marks time.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage